\-\ Texto\\:\\ \ \(0\)\
\-\ \\"bipolar\\"\\ mass\\ involving\\ the\\ petrous\\ bone\\ and\\ posterior\\ fossa\ \(0\)\
\-\ destructive\\ petrous\\ \\(temporal\\ bone\\)\\ mass\ \(0\)\
\-\ posteromedial\\,\\ near\\ vestibular\\ aqueduct\ \(1\)\
\-\ extends\\ to\\ middle\\ ear\ \(1\)\
\-\ erosion\\ includes\\ right\\ sigmoid\\ area\ \(1\)\
\-\ heterogeneous\\ mixed\\ cystic\\ and\\ solid\ \(1\)\
\-\ hyperintense\\ on\\ \\ both\\ t1w\\ and\\ t2w\\ \ \(0\)\
\-\ proteinaceous\\ and\\/or\\ hemorrhagic\\ fluid\ \(1\)\
\-\ endolymphatic\\ sac\\ tumor\ \(1\)\
\-\ endolymphatic\\ sac\\ tumor\ \(1\)\
\-\ \\	\\"heffner\\ tumor\\"\ \(0\)\
\-\ \\	cystic\\ and\\ papillary\\ adenocarcinoma\ \(1\)\
\-\ chondroid\\ tumor\ \(2\)\
\-\ \\	chondroma\\/chondrosarcoma\ \(0\)\
\-\ \\	chondromyxoid\\ fibroma\ \(0\)\
\-\ other\\ destructive\\ petrous\\ masses\ \(0\)\
\-\ \\	cholesterol\\ granuloma\ \(1\)\
\-\ \\	epidermoid\ \(1\)\
\-\ \\	metastasis\ \(1\)\
\-\ a\\ 54\\-year\\-old\\ woman\\ presented\\ with\\ chronic\\ ear\\ pain\\.\ \(0\)\
\-\ diagnosis\\:\\ \\ cystic\\ and\\ papillary\\ neoplasm\\ of\\ endolymphatic\\ sac\\ origin\\ \\(heffner\\ tumor\\)\\.\ \(0\)\
\-\ discussant\\:\\ \\ mahmood\\ f\\.\\ mafee\\,\\ md\\ \ \(0\)\
\-\ discussion\\:\\	\ \(0\)\
\-\ the\\ membranous\\ labyrinth\\ or\\ cavity\\ consists\\ of\\ the\\ cochlear\\ aqueduct\\,\\ the\\ vestibular\\ organ\\,\\ the\\ endolymphatic\\ duct\\ and\\ sac\\,\\ the\\ round\\ window\\ membrane\\,\\ and\\ their\\ associated\\ vasculature\\.\\ \\ the\\ bony\\ labyrinth\\ includes\\ the\\ vestibule\\,\\ the\\ semicircular\\ canals\\,\\ and\\ the\\ cochlea\\.\\ \\ the\\ membranous\\ labyrinth\\ of\\ the\\ inner\\ ear\\ begins\\ to\\ form\\ during\\ the\\ early\\ months\\ of\\ gestation\\.\\ \\ by\\ mid\\-term\\,\\ the\\ mesenchyme\\ that\\ surrounds\\ the\\ labyrinth\\ has\\ transformed\\ into\\ cartilage\\,\\ and\\ begins\\ to\\ ossify\\.\\ \\ the\\ endolymphatic\\ duct\\ and\\ sac\\ are\\ the\\ only\\ portions\\ that\\ grow\\ after\\ birth\\,\\ and\\ they\\ continue\\ to\\ enlarge\\ until\\ sometime\\ after\\ puberty\\.\ \(0\)\
\-\ there\\ is\\ considerable\\ controversy\\ concerning\\ the\\ origin\\ of\\ these\\ slowly\\ growing\\,\\ yet\\ highly\\ destructive\\ lesions\\ of\\ the\\ temporal\\ bone\\.\\ \\ several\\ recent\\ reports\\ have\\ emphasized\\ that\\ these\\ tumors\\ probably\\ do\\ arise\\ from\\ the\\ epithelial\\ elements\\ lining\\ the\\ endolymphatic\\ system\\ \\(especially\\ the\\ sac\\)\\.\\ \\ the\\ most\\ common\\ presentation\\ is\\ hearing\\ loss\\,\\ facial\\ nerve\\ palsy\\,\\ and\\ vestibular\\ dysfunction\\.\\ \ \(0\)\
\-\ there\\ appear\\ to\\ be\\ at\\ least\\ 2\\ categories\\ of\\ this\\ lesion\\,\\ a\\ slowly\\ growing\\,\\ relatively\\ benign\\ adenomatous\\ tumor\\,\\ and\\ a\\ more\\ aggressive\\ lesion\\ with\\ a\\ capillary\\ configuration\\.\\ \\ the\\ papillary\\ lesions\\ probably\\ arise\\ within\\ the\\ posterior\\ aspects\\ of\\ the\\ petrous\\ bone\\ in\\ the\\ retrolabyrinthine\\ region\\.\\ \\ the\\ lesions\\ may\\ be\\ hypervascular\\,\\ supplied\\ by\\ \\ branches\\ of\\ the\\ external\\ carotid\\ artery\\,\\ and\\ may\\ contain\\ blood\\ products\\ that\\ produce\\ characteristic\\ regions\\ of\\ hyperintensity\\ on\\ t1wi\\ and\\ hypointensity\\ on\\ t2wi\\.\\ \\ intratumoral\\ calcifications\\ within\\ these\\ lesions\\ may\\ represent\\ \\"bone\\ sequestra\\"\\ produced\\ when\\ the\\ tumor\\ infiltrates\\ into\\ the\\ petrous\\ bone\\.\\ \\ because\\ these\\ lesions\\ may\\ be\\ surrounded\\ by\\ a\\ thin\\ shell\\ of\\ reactive\\ bone\\,\\ it\\ has\\ been\\ suggested\\ that\\ at\\ least\\ during\\ some\\ portion\\ of\\ their\\ growth\\,\\ they\\ may\\ expand\\ relatively\\ slowly\\.\\ \\ the\\ lesions\\ almost\\ invariably\\ show\\ contrast\\ enhancement\\.\\ \\ some\\ of\\ the\\ tumors\\ have\\ a\\ speckled\\ pattern\\ of\\ hyperintensity\\ on\\ t1wi\\,\\ which\\ can\\ mimic\\ the\\ appearance\\ of\\ other\\ vascular\\ lesions\\ of\\ the\\ petrous\\ apex\\,\\ including\\ glomus\\ tumors\\.\ \(0\)\
\-\ the\\ papillary\\ endolymphatic\\ sac\\ tumor\\ has\\ been\\ associated\\ with\\ von\\ hippel\\-lindau\\ disease\\ \\(vhl\\)and\\ may\\ present\\ with\\ bilateral\\ papillary\\ endolymphatic\\ sac\\ neoplasms\\.\\ \\ it\\ is\\ also\\ interesting\\ to\\ remember\\ that\\ patients\\ with\\ vhl\\ may\\ develop\\ cystadenomas\\ in\\ the\\ testis\\ and\\ in\\ relationship\\ to\\ the\\ female\\ pelvic\\ adnexa\\.\\ \\ \ \(0\)\
\-\ in\\ this\\ patient\\,\\ the\\ differential\\ diagnosis\\ could\\ include\\ chondroid\\ lesions\\ \\(benign\\ chondroma\\ as\\ well\\ as\\ low\\-grade\\ chondrosarcoma\\,\\ and\\ chondromyxoid\\ fibroma\\)\\,\\ cholesterol\\ granuloma\\,\\ metastatic\\ disease\\,\\ and\\ possibly\\ an\\ aggressive\\ epidermoid\\ cyst\\.\ \(0\)\
\-\ because\\ the\\ histology\\ of\\ this\\ lesion\\ may\\ be\\ confusing\\ to\\ surgical\\ pathologists\\,\\ an\\ accurate\\ preoperative\\ localization\\ by\\ neuroimaging\\ can\\ assist\\ in\\ suggesting\\ the\\ correct\\ diagnosis\\.\\ \\ the\\ prognosis\\ can\\ be\\ quite\\ good\\ after\\ careful\\ gross\\ removal\\ of\\ the\\ lesion\\.\\ \\ however\\,\\ incomplete\\ resection\\ is\\ associated\\ with\\ recurrence\\.\ \(0\)\
\-\ suggested\\ readings\\:\ \(0\)\
\-\ batsakis\\,\\ j\\.g\\.\\ and\\ el\\-naggar\\,\\ a\\.k\\.\\ papillary\\ neoplasms\\ \\(heffner\\'s\\ tumors\\)\\ of\\ the\\ endolymphatic\\ sac\\ \\[see\\ comments\\]\\.\\ ann\\ otol\\ rhinol\\ laryngol\\.\\ 1993\\;102\\:648\\-651\ \(0\)\
\-\ delisle\\,\\ m\\.b\\.\\,\\ uro\\,\\ e\\.\\,\\ rouquette\\,\\ i\\.\\,\\ yardeni\\,\\ e\\.\\,\\ and\\ rumeau\\,\\ j\\.l\\.\\ papillary\\ neoplasm\\ of\\ the\\ endolymphatic\\ sac\\ in\\ a\\ patient\\ with\\ von\\ hippel\\-lindau\\ disease\\.\\ j\\ clin\\.pathol\\ 1994\\;47\\:959\\-961\\.\\ \ \(0\)\
\-\ heffner\\,\\ d\\.k\\.\\ low\\-grade\\ adenocarcinoma\\ of\\ probable\\ endolymphatic\\ sac\\ origin\\ a\\ clinicopathologic\\ study\\ of\\ 20\\ cases\\.\\ cancer\\ 1989\\;64\\:2292\\-2302\\.\ \(0\)\
\-\ mukherji\\,\\ s\\.k\\.\\ and\\ castillo\\,\\ m\\.\\ adenocarcinoma\\ of\\ the\\ endolymphatic\\ sac\\:\\ imaging\\ features\\ and\\ preoperative\\ embolization\\.\\ neuroradiol\\ 1996\\;38\\:179\\-180\\,\\.\ \(0\)\
\-\ mukherji\\,\\ s\\.k\\.\\,\\ albernaz\\,\\ v\\.s\\.\\,\\ lo\\,\\ w\\.w\\.\\,\\ gaffey\\,\\ m\\.j\\.\\,\\ mergerian\\,\\ c\\.a\\.\\,\\ feghali\\,\\ j\\.g\\.\\,\\ brook\\,\\ a\\.\\,\\ lewin\\,\\ j\\.s\\.\\,\\ lanzieri\\,\\ c\\.f\\.\\,\\ talbot\\,\\ j\\.m\\.\\,\\ meyer\\,\\ j\\.r\\.\\,\\ carmody\\,\\ r\\.f\\.\\,\\ weissman\\,\\ j\\.l\\.\\,\\ smirniotopoulos\\,\\ j\\.g\\.\\,\\ rao\\,\\ v\\.m\\.\\,\\ jinkins\\,\\ j\\.r\\.\\,\\ and\\ castillo\\,\\ m\\.\\ papillary\\ endolymphatic\\ sac\\ tumours\\:\\ ct\\,\\ mr\\ imaging\\,\\ and\\ angiographic\\ findings\\ in\\ 20\\ patients\\.\\ radiology\\ 1997\\;202\\(3\\)\\:801\\-808\\.\ \(0\)\
\-\ tibbs\\ jr\\.\\,\\ r\\.e\\.\\,\\ bowles\\ jr\\.\\,\\ a\\.p\\.\\,\\ raila\\,\\ f\\.a\\.\\,\\ fratkin\\,\\ j\\.d\\.\\,\\ and\\ hutchins\\,\\ j\\.b\\.\\ should\\ endolymphatic\\ sac\\ tumors\\ be\\ considered\\ part\\ of\\ the\\ von\\ hippel\\-lindau\\ complex\\?\\ pathology\\ case\\ report\\.\\ neurosurg\\ 1997\\;40\\(4\\)\\:848\\-855\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endolymphatic\\:\\ 0\\.5153053585487412\ \(0\)\
\-\ sac\\:\\ 0\\.3105186399401115\ \(0\)\
\-\ the\\:\\ 0\\.23359752042379744\ \(0\)\
\-\ papillary\\:\\ 0\\.18569690609887263\ \(0\)\
\-\ petrous\\:\\ 0\\.16894395037994253\ \(0\)\
\-\ heffner\\:\\ 0\\.15933683172033092\ \(0\)\
\-\ labyrinth\\:\\ 0\\.15933683172033092\ \(0\)\
\-\ and\\:\\ 0\\.1389703147863323\ \(0\)\
\-\ of\\:\\ 0\\.11698787237132656\ \(0\)\
\-\ lesions\\:\\ 0\\.11444214241832228\ \(0\)\
\-\ tumor\\:\\ 0\\.10422897095193769\ \(0\)\
\-\ may\\:\\ 0\\.10027817715049132\ \(0\)\
\-\ bone\\:\\ 0\\.09513620173942389\ \(0\)\
\-\ tumors\\:\\ 0\\.09159481319657466\ \(0\)\
\-\ von\\:\\ 0\\.08277933526829745\ \(0\)\
\-\ mukherji\\:\\ 0\\.07966841586016546\ \(0\)\
\-\ destructive\\:\\ 0\\.07962017533532809\ \(0\)\
\-\ vestibular\\:\\ 0\\.07707678227564532\ \(0\)\
\-\ slowly\\:\\ 0\\.07369928830992238\ \(0\)\
\-\ castillo\\:\\ 0\\.07361505122124874\ \(0\)\
\-\ vhl\\:\\ 0\\.0687278374850099\ \(0\)\
\-\ ear\\:\\ 0\\.06799673531727025\ \(0\)\
\-\ that\\:\\ 0\\.06485628213091725\ \(0\)\
\-\ origin\\:\\ 0\\.06432485281164062\ \(0\)\
\-\ membranous\\:\\ 0\\.0640206952653743\ \(0\)\
\-\ chondromyxoid\\:\\ 0\\.06332166956084397\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.061075897323620995\ \(0\)\
\-\ be\\:\\ 0\\.06062643878651089\ \(0\)\
\-\ aqueduct\\:\\ 0\\.060479703948416556\ \(0\)\
\-\ chondroma\\:\\ 0\\.05955957379755034\ \(0\)\
\-\ chondroid\\:\\ 0\\.05913348152913544\ \(0\)\
\-\ these\\:\\ 0\\.05626343657091517\ \(0\)\
\-\ cholesterol\\:\\ 0\\.055186223512198304\ \(0\)\
\-\ begins\\:\\ 0\\.05467236006131148\ \(0\)\
\-\ t1wi\\:\\ 0\\.054426339309499853\ \(0\)\
\-\ preoperative\\:\\ 0\\.054187059707498236\ \(0\)\
\-\ fibroma\\:\\ 0\\.050111997080706024\ \(0\)\
\-\ to\\:\\ 0\\.04981672592649894\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.04967885910061791\ \(0\)\
\-\ 1997\\:\\ 0\\.04926619213714555\ \(0\)\
\-\ growing\\:\\ 0\\.04887214819513791\ \(0\)\
\-\ probably\\:\\ 0\\.04837297467058314\ \(0\)\
\-\ lesion\\:\\ 0\\.0477668685414701\ \(0\)\
\-\ suggested\\:\\ 0\\.046620485551322616\ \(0\)\
\-\ neoplasms\\:\\ 0\\.04642422652471816\ \(0\)\
\-\ least\\:\\ 0\\.04604446412169906\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.045680529832020894\ \(0\)\
\-\ arise\\:\\ 0\\.04559186755632385\ \(0\)\
\-\ granuloma\\:\\ 0\\.04507800410543703\ \(0\)\
\-\ cystic\\:\\ 0\\.045004732527136354\ \(0\)\
\-\ in\\:\\ 0\\.04337508709157986\ \(0\)\
\-\ epidermoid\\:\\ 0\\.04328026535569398\ \(0\)\
\-\ aggressive\\:\\ 0\\.04307949423436488\ \(0\)\
\-\ duct\\:\\ 0\\.04288323520776041\ \(0\)\
\-\ by\\:\\ 0\\.04231047457949747\ \(0\)\
\-\ their\\:\\ 0\\.04134506749826545\ \(0\)\
\-\ relatively\\:\\ 0\\.0405671209124059\ \(0\)\
\-\ discussant\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ transformed\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ retrolabyrinthine\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ batsakis\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ otol\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ rhinol\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ laryngol\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ delisle\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ uro\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ rouquette\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ yardeni\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ rumeau\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ albernaz\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ gaffey\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ mergerian\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ feghali\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ brook\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ lewin\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ lanzieri\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ talbot\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ carmody\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ weissman\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ jinkins\\:\\ 0\\.03983420793008273\ \(0\)\
\-\ associated\\:\\ 0\\.039386034919640156\ \(0\)\
\-\ can\\:\\ 0\\.039213667449646904\ \(0\)\
\-\ includes\\:\\ 0\\.038738280725462336\ \(0\)\
\-\ diagnosis\\:\\ 0\\.038737260813223366\ \(0\)\
\-\ temporal\\:\\ 0\\.03826822149095419\ \(0\)\
\-\ mahmood\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ mafee\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ sometime\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ controversy\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ pathologists\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ readings\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ clinicopathologic\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ smirniotopoulos\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ tibbs\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ bowles\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ raila\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ fratkin\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ hutchins\\:\\ 0\\.038063712271603864\ \(0\)\
\-\ mesenchyme\\:\\ 0\\.03680752561062437\ \(0\)\
\-\ lo\\:\\ 0\\.03680752561062437\ \(0\)\
\-\ after\\:\\ 0\\.03625065041166334\ \(0\)\
\-\ ossify\\:\\ 0\\.035833151537691885\ \(0\)\
\-\ sequestra\\:\\ 0\\.035833151537691885\ \(0\)\
\-\ rao\\:\\ 0\\.035833151537691885\ \(0\)\
\-\ they\\:\\ 0\\.035595255536198474\ \(0\)\
\-\ bipolar\\:\\ 0\\.035037029952145506\ \(0\)\
\-\ emphasized\\:\\ 0\\.035037029952145506\ \(0\)\
\-\ speckled\\:\\ 0\\.035037029952145506\ \(0\)\
\-\ cystadenomas\\:\\ 0\\.035037029952145506\ \(0\)\
\-\ meyer\\:\\ 0\\.035037029952145506\ \(0\)\
\-\ because\\:\\ 0\\.034816670771439504\ \(0\)\
\-\ intratumoral\\:\\ 0\\.03436391874250495\ \(0\)\
\-\ invariably\\:\\ 0\\.03436391874250495\ \(0\)\
\-\ comments\\:\\ 0\\.03436391874250495\ \(0\)\
\-\ benign\\:\\ 0\\.03422099726893825\ \(0\)\
\-\ with\\:\\ 0\\.034141850340847595\ \(0\)\
\-\ has\\:\\ 0\\.034132511484428765\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03400769376920884\ \(0\)\
\-\ cochlear\\:\\ 0\\.03326653429366663\ \(0\)\
\-\ vestibule\\:\\ 0\\.03326653429366663\ \(0\)\
\-\ confusing\\:\\ 0\\.03326653429366663\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.03326653429366663\ \(0\)\
\-\ 202\\:\\ 0\\.03326653429366663\ \(0\)\
\-\ semicircular\\:\\ 0\\.032806469218233526\ \(0\)\
\-\ expand\\:\\ 0\\.032806469218233526\ \(0\)\
\-\ cochlea\\:\\ 0\\.032390289734036376\ \(0\)\
\-\ shell\\:\\ 0\\.032390289734036376\ \(0\)\
\-\ tumours\\:\\ 0\\.032390289734036376\ \(0\)\
\-\ 20\\:\\ 0\\.032138915859209305\ \(0\)\
\-\ ann\\:\\ 0\\.03201034763268715\ \(0\)\
\-\ during\\:\\ 0\\.03155405072336645\ \(0\)\
\-\ disease\\:\\ 0\\.031367184144971985\ \(0\)\
\-\ some\\:\\ 0\\.031344444842411605\ \(0\)\
\-\ 1989\\:\\ 0\\.03133723642304659\ \(0\)\
\-\ enlarge\\:\\ 0\\.031035973559754657\ \(0\)\
\-\ neurosurg\\:\\ 0\\.031035973559754657\ \(0\)\
\-\ puberty\\:\\ 0\\.03075416097170766\ \(0\)\
\-\ proteinaceous\\:\\ 0\\.030489438736485668\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.030239851974208278\ \(0\)\
\-\ on\\:\\ 0\\.030091249073453487\ \(0\)\
\-\ assist\\:\\ 0\\.02977978689877517\ \(0\)\
\-\ posteromedial\\:\\ 0\\.02956674076456772\ \(0\)\
\-\ considerable\\:\\ 0\\.02956674076456772\ \(0\)\
\-\ categories\\:\\ 0\\.02956674076456772\ \(0\)\
\-\ remember\\:\\ 0\\.02936360741457802\ \(0\)\
\-\ supplied\\:\\ 0\\.02916950525616887\ \(0\)\
\-\ angiographic\\:\\ 0\\.02916950525616887\ \(0\)\
\-\ been\\:\\ 0\\.029024016810666468\ \(0\)\
\-\ canals\\:\\ 0\\.028983665313228792\ \(0\)\
\-\ surrounds\\:\\ 0\\.028983665313228792\ \(0\)\
\-\ 1993\\:\\ 0\\.028983665313228792\ \(0\)\
\-\ lining\\:\\ 0\\.028805412825842678\ \(0\)\
\-\ adenomatous\\:\\ 0\\.028805412825842678\ \(0\)\
\-\ grow\\:\\ 0\\.028469356315729413\ \(0\)\
\-\ accurate\\:\\ 0\\.028469356315729413\ \(0\)\
\-\ localization\\:\\ 0\\.028469356315729413\ \(0\)\
\-\ 1994\\:\\ 0\\.028310554103588233\ \(0\)\
\-\ glomus\\:\\ 0\\.028157325063323753\ \(0\)\
\-\ patients\\:\\ 0\\.028024853005966403\ \(0\)\
\-\ hypointensity\\:\\ 0\\.02786611186976731\ \(0\)\
\-\ adnexa\\:\\ 0\\.02786611186976731\ \(0\)\
\-\ mimic\\:\\ 0\\.027727478652249306\ \(0\)\
\-\ careful\\:\\ 0\\.027593111756099152\ \(0\)\
\-\ infiltrates\\:\\ 0\\.02746275641702731\ \(0\)\
\-\ is\\:\\ 0\\.027285512088115534\ \(0\)\
\-\ testis\\:\\ 0\\.02697708083080233\ \(0\)\
\-\ 1996\\:\\ 0\\.02697708083080233\ \(0\)\
\-\ epithelial\\:\\ 0\\.026753104579316813\ \(0\)\
\-\ quite\\:\\ 0\\.026753104579316813\ \(0\)\
\-\ t2wi\\:\\ 0\\.026645282321584862\ \(0\)\
\-\ into\\:\\ 0\\.02648192198817033\ \(0\)\
\-\ relationship\\:\\ 0\\.026437310655784214\ \(0\)\
\-\ histology\\:\\ 0\\.026437310655784214\ \(0\)\
\-\ hypervascular\\:\\ 0\\.026336925095119663\ \(0\)\
\-\ products\\:\\ 0\\.026336925095119663\ \(0\)\
\-\ interesting\\:\\ 0\\.026336925095119663\ \(0\)\
\-\ imaging\\:\\ 0\\.02618058109316948\ \(0\)\
\-\ membrane\\:\\ 0\\.026142822936710514\ \(0\)\
\-\ capillary\\:\\ 0\\.026142822936710514\ \(0\)\
\-\ correct\\:\\ 0\\.026142822936710514\ \(0\)\
\-\ other\\:\\ 0\\.02587082884823752\ \(0\)\
\-\ aspects\\:\\ 0\\.025778730506384323\ \(0\)\
\-\ probable\\:\\ 0\\.025778730506384323\ \(0\)\
\-\ posterior\\:\\ 0\\.0257608610681203\ \(0\)\
\-\ this\\:\\ 0\\.02567708798124321\ \(0\)\
\-\ organ\\:\\ 0\\.025607470141505266\ \(0\)\
\-\ window\\:\\ 0\\.025607470141505266\ \(0\)\
\-\ surrounded\\:\\ 0\\.025607470141505266\ \(0\)\
\-\ t1w\\:\\ 0\\.02552429468245078\ \(0\)\
\-\ it\\:\\ 0\\.025500686084449737\ \(0\)\
\-\ produced\\:\\ 0\\.025362551022187173\ \(0\)\
\-\ yet\\:\\ 0\\.025206585172323465\ \(0\)\
\-\ t2w\\:\\ 0\\.025130642743865395\ \(0\)\
\-\ configuration\\:\\ 0\\.025130642743865395\ \(0\)\
\-\ produce\\:\\ 0\\.024982608920837944\ \(0\)\
\-\ palsy\\:\\ 0\\.024910432408587976\ \(0\)\
\-\ contain\\:\\ 0\\.024910432408587976\ \(0\)\
\-\ have\\:\\ 0\\.02488638266336973\ \(0\)\
\-\ consists\\:\\ 0\\.024769562786630492\ \(0\)\
\-\ gestation\\:\\ 0\\.024700796332790948\ \(0\)\
\-\ elements\\:\\ 0\\.024700796332790948\ \(0\)\
\-\ branches\\:\\ 0\\.024700796332790948\ \(0\)\
\-\ vasculature\\:\\ 0\\.02450076534852509\ \(0\)\
\-\ continue\\:\\ 0\\.024436074097568955\ \(0\)\
\-\ incomplete\\:\\ 0\\.024436074097568955\ \(0\)\
\-\ inner\\:\\ 0\\.024372327278231642\ \(0\)\
\-\ dysfunction\\:\\ 0\\.02418648733529157\ \(0\)\
\-\ concerning\\:\\ 0\\.023893318227000235\ \(0\)\
\-\ portions\\:\\ 0\\.023672178337792185\ \(0\)\
\-\ cartilage\\:\\ 0\\.023618600002126504\ \(0\)\
\-\ apex\\:\\ 0\\.023410628336325855\ \(0\)\
\-\ possibly\\:\\ 0\\.023410628336325855\ \(0\)\
\-\ erosion\\:\\ 0\\.023116140617252156\ \(0\)\
\-\ sigmoid\\:\\ 0\\.023068933891830085\ \(0\)\
\-\ within\\:\\ 0\\.022944228069456507\ \(0\)\
\-\ develop\\:\\ 0\\.022930300674312083\ \(0\)\
\-\ md\\:\\ 0\\.022708599275481623\ \(0\)\
\-\ hearing\\:\\ 0\\.022622977324866664\ \(0\)\
\-\ suggesting\\:\\ 0\\.022456611314588527\ \(0\)\
\-\ almost\\:\\ 0\\.02237574641890357\ \(0\)\
\-\ highly\\:\\ 0\\.02229635187581189\ \(0\)\
\-\ birth\\:\\ 0\\.02225718946467152\ \(0\)\
\-\ part\\:\\ 0\\.02225718946467152\ \(0\)\
\-\ gross\\:\\ 0\\.02210396042440704\ \(0\)\
\-\ prognosis\\:\\ 0\\.021919689218531668\ \(0\)\
\-\ discussion\\:\\ 0\\.021812747230850596\ \(0\)\
\-\ form\\:\\ 0\\.021777674113993475\ \(0\)\
\-\ embolization\\:\\ 0\\.02170836187181841\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.02160641374911442\ \(0\)\
\-\ regions\\:\\ 0\\.021377402041096293\ \(0\)\
\-\ reactive\\:\\ 0\\.021377402041096293\ \(0\)\
\-\ carotid\\:\\ 0\\.020981552528447096\ \(0\)\
\-\ report\\:\\ 0\\.020981552528447096\ \(0\)\
\-\ until\\:\\ 0\\.020727116704513552\ \(0\)\
\-\ represent\\:\\ 0\\.020727116704513552\ \(0\)\
\-\ do\\:\\ 0\\.020645496018333827\ \(0\)\
\-\ mixed\\:\\ 0\\.020618624674624046\ \(0\)\
\-\ cavity\\:\\ 0\\.02056537304424995\ \(0\)\
\-\ recurrence\\:\\ 0\\.02056537304424995\ \(0\)\
\-\ facial\\:\\ 0\\.02053898879737514\ \(0\)\
\-\ growth\\:\\ 0\\.02053898879737514\ \(0\)\
\-\ extends\\:\\ 0\\.0205127630154011\ \(0\)\
\-\ round\\:\\ 0\\.020409407194386237\ \(0\)\
\-\ near\\:\\ 0\\.02028356045620295\ \(0\)\
\-\ good\\:\\ 0\\.020258820562415784\ \(0\)\
\-\ external\\:\\ 0\\.02013718095392748\ \(0\)\
\-\ characteristic\\:\\ 0\\.02013718095392748\ \(0\)\
\-\ features\\:\\ 0\\.020042251572371727\ \(0\)\
\-\ as\\:\\ 0\\.020013304067759637\ \(0\)\
\-\ radiology\\:\\ 0\\.01994934211895313\ \(0\)\
\-\ there\\:\\ 0\\.01982207638748201\ \(0\)\
\-\ hyperintense\\:\\ 0\\.01981358259655209\ \(0\)\
\-\ especially\\:\\ 0\\.019703587370587868\ \(0\)\
\-\ appear\\:\\ 0\\.019617543609735656\ \(0\)\
\-\ fossa\\:\\ 0\\.019554105502588553\ \(0\)\
\-\ pathology\\:\\ 0\\.019554105502588553\ \(0\)\
\-\ pelvic\\:\\ 0\\.01947093004353407\ \(0\)\
\-\ considered\\:\\ 0\\.019409571943935007\ \(0\)\
\-\ thin\\:\\ 0\\.01938930935735434\ \(0\)\
\-\ reports\\:\\ 0\\.019369140362731168\ \(0\)\
\-\ bony\\:\\ 0\\.019191692848998847\ \(0\)\
\-\ complex\\:\\ 0\\.019191692848998847\ \(0\)\
\-\ solid\\:\\ 0\\.019096140249063007\ \(0\)\
\-\ an\\:\\ 0\\.01904989845177293\ \(0\)\
\-\ removal\\:\\ 0\\.019039796505089173\ \(0\)\
\-\ mass\\:\\ 0\\.01902880894829719\ \(0\)\
\-\ system\\:\\ 0\\.0190026339014363\ \(0\)\
\-\ at\\:\\ 0\\.018816555891123698\ \(0\)\
\-\ pattern\\:\\ 0\\.018596558346712973\ \(0\)\
\-\ 40\\:\\ 0\\.01831896263931493\ \(0\)\
\-\ metastasis\\:\\ 0\\.018256133072280672\ \(0\)\
\-\ calcifications\\:\\ 0\\.018178846460474258\ \(0\)\
\-\ could\\:\\ 0\\.018117987223430245\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.01802825982850381\ \(0\)\
\-\ early\\:\\ 0\\.01795487020898874\ \(0\)\
\-\ including\\:\\ 0\\.017825799346929436\ \(0\)\
\-\ middle\\:\\ 0\\.017811690838459748\ \(0\)\
\-\ portion\\:\\ 0\\.017811690838459748\ \(0\)\
\-\ nerve\\:\\ 0\\.017769636777553582\ \(0\)\
\-\ involving\\:\\ 0\\.017447035014858458\ \(0\)\
\-\ or\\:\\ 0\\.017330488063383324\ \(0\)\
\-\ presentation\\:\\ 0\\.01714663605098029\ \(0\)\
\-\ masses\\:\\ 0\\.016957269594204648\ \(0\)\
\-\ recent\\:\\ 0\\.01686557951515103\ \(0\)\
\-\ cases\\:\\ 0\\.016753609801442276\ \(0\)\
\-\ study\\:\\ 0\\.016612213800173373\ \(0\)\
\-\ cancer\\:\\ 0\\.0165908612902773\ \(0\)\
\-\ vascular\\:\\ 0\\.01644424772407571\ \(0\)\
\-\ several\\:\\ 0\\.01634245804327281\ \(0\)\
\-\ should\\:\\ 0\\.01625283296727316\ \(0\)\
\-\ patient\\:\\ 0\\.016203007397969607\ \(0\)\
\-\ differential\\:\\ 0\\.01618437455050987\ \(0\)\
\-\ area\\:\\ 0\\.016136124561536635\ \(0\)\
\-\ mr\\:\\ 0\\.016116972866043095\ \(0\)\
\-\ resection\\:\\ 0\\.015966710140279502\ \(0\)\
\-\ show\\:\\ 0\\.01581252620416124\ \(0\)\
\-\ only\\:\\ 0\\.015561454463269772\ \(0\)\
\-\ see\\:\\ 0\\.015494660356711888\ \(0\)\
\-\ artery\\:\\ 0\\.015469873651143221\ \(0\)\
\-\ loss\\:\\ 0\\.015175206830756042\ \(0\)\
\-\ when\\:\\ 0\\.015046210738254752\ \(0\)\
\-\ appearance\\:\\ 0\\.015016404618614865\ \(0\)\
\-\ region\\:\\ 0\\.014899173965025587\ \(0\)\
\-\ include\\:\\ 0\\.014820365631798428\ \(0\)\
\-\ chronic\\:\\ 0\\.014785008519001393\ \(0\)\
\-\ however\\:\\ 0\\.014742954458095226\ \(0\)\
\-\ presented\\:\\ 0\\.014525260553813391\ \(0\)\
\-\ months\\:\\ 0\\.014498796354186607\ \(0\)\
\-\ blood\\:\\ 0\\.014465940069951536\ \(0\)\
\-\ fluid\\:\\ 0\\.014381653066261393\ \(0\)\
\-\ cyst\\:\\ 0\\.014368829034804242\ \(0\)\
\-\ enhancement\\:\\ 0\\.014336932767539872\ \(0\)\
\-\ common\\:\\ 0\\.01412600581783052\ \(0\)\
\-\ both\\:\\ 0\\.013890235757220124\ \(0\)\
\-\ more\\:\\ 0\\.013677462867252467\ \(0\)\
\-\ metastatic\\:\\ 0\\.013661098402480447\ \(0\)\
\-\ bilateral\\:\\ 0\\.013386778582093476\ \(0\)\
\-\ woman\\:\\ 0\\.012972458799616358\ \(0\)\
\-\ most\\:\\ 0\\.012963168201276146\ \(0\)\
\-\ present\\:\\ 0\\.01278139046302912\ \(0\)\
\-\ case\\:\\ 0\\.01251378902043178\ \(0\)\
\-\ findings\\:\\ 0\\.01229337279373328\ \(0\)\
\-\ surgical\\:\\ 0\\.012106372033627891\ \(0\)\
\-\ contrast\\:\\ 0\\.012102560091375652\ \(0\)\
\-\ well\\:\\ 0\\.012060846899390585\ \(0\)\
\-\ female\\:\\ 0\\.012019528418796395\ \(0\)\
\-\ also\\:\\ 0\\.01171627213863687\ \(0\)\
\-\ which\\:\\ 0\\.011326169457957145\ \(0\)\
\-\ from\\:\\ 0\\.00989262349244779\ \(0\)\
\-\ ct\\:\\ 0\\.009482922149074233\ \(0\)\
\-\ are\\:\\ 0\\.009451665182589023\ \(0\)\
\-\ pain\\:\\ 0\\.008913198961531641\ \(0\)\
\-\ right\\:\\ 0\\.008258217813169108\ \(0\)\
